IGF::CL::IGFMindfulness-Based Substance Abuse Prevention Program for Adolescents with FASD. August 1, 2013 - September 20, 2016Cost Plus Fixed Fee - Completion (SBIR Phase II)

Agency: National Institute of Health (NIH)
Institute: Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type: Small Business Innovation Research â€“ Phase II (N44)
Project #: 275201300008C-7-0-1
Application #: 9581081
Study Section


NIH 2017 N44 HD	IGF::CL::IGFMindfulness-Based Substance Abuse Prevention Program for Adolescents with FASD. August 1, 2013 - September 20, 2016Cost Plus Fixed Fee - Completion (SBIR Phase II) Parker, Alison / Innovation Research and Training, Inc.
NIH 2016 N44 HD	IGF::OT::IGF -- Biomarkers for Alcohol and ALD Nielsen, Paul / Echelon Biosciences, Inc.
NIH 2016 N44 HD	Development of A Database of Non-English Measures & Instruments for Use in Alcohol Researchperiod of Performance 2/29/16 - 2/28/18igf::Ot::Igf Yang, Dershung / Brightoutcome Inc.
NIH 2016 N44 HD	Igf::Ot::Igf Potential Commercialization of Proprietary Compound JR-220 Littleton, John / Naprogenix, Inc
NIH 2015 N44 HD	Development of Nociceptin Receptor Agonists for Alcohol Use Disorders, Period of Performance 09/15/15 - 09/14/17; CPFF Zaveri, Nurulain / Astraea Therapeutics, LLC